The Orthopaedic Implant Company Launches Semi-Extended Tibial Nail Platform

Biedermann Motech to Launch MDS Injection Screw for its Polyaxial Humerus Plating Systems

Miami, FL – October 17, 2018 / Business Wire / – Biedermann Motech, the leading innovator of polyaxial screw technologies, announced today the launch of the first injection screw that can be used through, and in combination with, its polyaxial locking plate systems at the 2018 Orthopaedic Trauma Association (OTA) Annual Meeting in Kissimmee (Orlando), October 17-20, 2018.

The MDS Injection Screw can be utilized to deliver injectable bone void fillers to a surgical site and is compatible with MDS humerus plating systems. It was developed as an innovative option for the systems to offer stable fixation in osteoporotic and complex fractures.

The current MDS plating systems utilize Next Generation Polyaxial Locking TechnologyTM, which includes 40-degree polyaxial locking for optimal plate and screw placement, a strong and consistent locking mechanism at every screw angle and a low profile construct. By adding the MDS Injection Screw to the system, surgeons will have additional options in the treatment of complex humeral fractures. Biedermann Motech is the first company to offer such a technology for extremity surgery.

“Biedermann Motech first introduced the combination of fenestrated augmentable polyaxial screws for complex spine reconstructions more than 15 years ago,” said Markku Biedermann, Chairman of Biedermann Motech, Inc., “and we are very excited to now introduce this sophisticated technology for the fixation of bone fractures and bone reconstructions of the humerus.”

Biedermann Motech will showcase the MDS Injection Screw Technology Platform at the up-coming 2018 Orthopaedic Trauma Association (OTA) Annual Meeting in Kissimmee (Orlando), October 17-20, 2018 at booth number 1015.

More information is available at or call 866-622-6082. Follow us on LinkedIn

About Biedermann Motech

Biedermann Motech is a mid-sized, family owned group of companies with headquarters in Germany (Villingen-Schwenningen) and the USA (Miami). Since 1916 we have been working in synergy with world-class surgeons to solve significant clinical challenges through the development of next-generation technology. Our core competency is the development, production, and distribution of innovative implants and instruments for spinal and extremity surgery. We research, develop, manufacture and distribute high-quality implant systems in collaboration with healthcare professionals, technology partners, scientific institutions and specialized companies with the goal of achieving improved clinical outcomes.

Contact: Serina Prado

Biedermann Motech, Inc – USA

7620 NW 25th Street, Unit 3 & 4

Miami, FL 33122

UCHealth University of Colorado Hospital now one of the state’s few Level I trauma centers

Aurora, Colo., Oct. 16, 2018 (GLOBE NEWSWIRE) —

The Colorado Department of Public Health and Environment (CDPHE) and American College of Surgeons have verified and designated UCHealth University of Colorado Hospital (UCH) on the Anschutz Medical Campus as a Level I trauma center, making it one of only five hospitals in the state with the highest capabilities for trauma care. The Level I distinction recognizes the hospital’s ability to treat the most severe and complex injuries, giving residents of Aurora, metro Denver, eastern Colorado, and the broader Rocky Mountain region rapid access to the most advanced trauma care.

  • Level I is the highest trauma center designation.
  • University of Colorado Hospital is home to the only American Burn Association Verified Burn Center in Colorado.
  • University of Colorado Hospital has the largest neurological intensive care unit in the state and is one of the few Comprehensive Stroke Centers. 
  • University of Colorado Hospital is home to a full-service orthopedic trauma service and the Limb Restoration Program, dedicated to the treatment of conditions that can put limbs at risk.
  • Nationally recognized surgeons, emergency and trauma physicians from University of Colorado School of Medicine provide expert care for patients.

The hospital received official designation by the Colorado Department of Public Health and Environment on Oct. 12, 2018.

“Earning this Level I designation has taken years of planning and advancements,” said Will Cook, UCHealth University of Colorado Hospital’s president and CEO. “The CU School of Medicine and UCH have recruited some of the nation’s best trauma surgeons, led important research, and improved every aspect of our trauma patient care. This preparation, and the Level I designation, will result in more lives being saved.”

Hospital trauma designations are determined according to established state and national criteria. Key elements required to be a Level I trauma center include around-the-clock coverage by trauma surgeons and prompt availability of the most comprehensive group of specialists in orthopedics, neurosurgery, and anesthesiology, among others. Such facilities also must be leaders in trauma prevention and education, conduct research, and meet volume requirements for treating severely injured patients.

The majority of trauma cases involve blunt injuries that are often the result of incidents such as motor vehicle crashes, pedestrians or bicyclists hit by vehicles, falls, and penetrating trauma injuries such as gunshot wounds and stabbings. UCH also serves as a regional referral destination for patients from dozens of hospitals in Colorado, Wyoming, Kansas and Nebraska.

“Excellent trauma care depends on a large team of specialists, nurses, surgeons, therapists and support staff. Only by working together can we provide patients with the highest level of care possible,” said Dr. Robert McIntyre, the hospital’s trauma medical director and CU School of Medicine professor. “Not only are we providing excellent trauma care today, but the research and education we are leading will help define the future of trauma medicine.”

Patients with the most serious burns often include life-threatening trauma injuries as well, and UCH now provides these patients with the most advanced capabilities for both types of injuries.

“As the first and only Burn Center in our region verified by the American Burn Association, University of Colorado Hospital already cares for patients from a multi-state region, providing a comprehensive team approach to care,” said Dr. Anne Wagner, medical director of the Burn Center and associate professor, CU School of Medicine. “Now these patients can benefit from the highest burn and trauma capabilities at the same location.”

Dave Repsher, a flight nurse and paramedic, was critically injured and burned when the medical transport helicopter he was flying in crashed in Summit County in July 2015. He was rushed to the Burn Center at UCH where he spent more than a year recovering from his injuries.

“I was flown to University of Colorado Hospital, desperately critical, and subsequently received care from an army of caregivers and staff,” Repsher said. “I spent 397 days in the hospital. I have been seen by over 42 specialties and ancillary services, have had 51 major surgeries and countless procedures, all here at the Anschutz Medical Campus. My recovery is due, in no small part, to having all of the dedicated services and specialties I needed including: burn, trauma and transplant all coordinated and centralized in one location.”

EDITORS’ NOTE: Downloadable photos and videos are available here.

About UCHealth

UCHealth is an innovative, nonprofit health system that delivers the highest quality medical care with an excellent patient experience. UCHealth combines Longs Peak HospitalYampa Valley Medical CenterMemorial Hospital CentralMemorial Hospital NorthPoudre Valley HospitalMedical Center of the RockiesUCHealth Medical GroupBroomfield HospitalGrandview HospitalPikes Peak Regional Hospital and University of Colorado Hospital into an organization dedicated to health and providing unmatched patient care in the Rocky Mountain West. With more than 150 clinic locations, UCHealth pushes the boundaries of medicine, providing advanced treatments and clinical trials and improving health through innovation.

Paula Freund

Amplitude Surgical: Mrs. Muriel Benedetto is Appointed to the Newly-Created Position of COO

October 15, 2018

VALENCE, France–(BUSINESS WIRE)–Regulatory News:

Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) (Paris:AMPLI), a leading French player on the global surgical technology market for lower-limb orthopedics, announces the appointment of Mrs. Muriel Benedetto Marmilloud to the newly-created position of Chief Operating Officer (COO). She will report directly to Olivier Jallabert, Chairman and CEO of Amplitude Surgical.

Olivier Jallabert, Chairman and CEO of Amplitude Surgical, says: “All of Amplitude Surgical’s staff members and I are delighted to welcome Muriel Benedetto Marmilloud to the newly-created position of Chief Operating Officer. Muriel is a senior executive who is recognized for her focus on innovation and her knowledge of global markets – in particular the US market. Her experience and strategic vision will be very valuable to our Group’s future growth, its global deployment and the expansion of its portfolio of innovative products”.

Graduated from the ECAM engineering school in Lyon, Muriel Benedetto Marmilloud has over twenty years of experience in the orthopedic medical device sector. She has notably been the global director of a product line generating over a billion-dollar at Zimmer Biomet, the global leader of this sector.

Muriel Benedetto Marmilloud will work alongside Chairman and CEO Olivier Jallabert, more focused on the Group’s strategic developments, and in particular international development. She will be in charge of steering the R&D, Supply chain and Quality assurance & Regulatory affairs departments, in order to ensure total control over the entire logistics value chain. Working in close collaboration with the current teams, she will also be responsible for continuing the structuring of operations in order to accompany the Company’s international development and comply with future regulatory changes.

About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. At June 30, 2018, Amplitude Surgical had a workforce of nearly 400 employees and recorded sales of over 100 million euros.


Amplitude Surgical
Philippe Garcia, +33 (0)4 75 41 87 41
Investor Relations
Marc Willaume, +33 (0)1 44 71 00 13
Media Relations
Nicolas Merigeau, +33 (0)1 44 71 98 55

Field Orthopaedics Forms Exclusive Partnership With Ortho Consulting Group to Launch New Micro Screw Into EMEA

BASINGSTOKE, EnglandOctober 15, 2018 /PRNewswire/ —

  • Partnering with Ortho Consulting Group, Field Orthopaedics is expanding its market presence for their innovative Micro Screw System in EMEA.
  • The unique 1.5mm screw with a rigid cannulation is designed for small fractures in the hand.
  • New to EMEA market, CE registration pending.

Innovators of the Micro Screw System, Australian-based Field Orthopaedics, has signed sales expansion experts, Ortho Consulting Group, to exclusively manage and accelerate growth of their new product in EMEA.

Already established in Australia, and most recently in the US, the Micro Screw is nearly set (CE registration imminent) to break into the EMEA market for the first time. Ortho Consulting Group will take full commercial responsibility for the expansion including setting the strategic direction as well as sourcing, onboarding and managing of distributors throughout the region.

Matt Woods, Founder of Ortho Consulting Group, said: We are delighted to be managing the EMEA region for Field Orthopaedics. Field are an innovative company with its first product offering being the Micro Screw, we are looking forward to a long partnership with Field.

Andrew Dubowski, Head of Export, It is very exciting to be able to offer such a small screw (1.5mm) with a cannulation that is still rigid and effective at fracture fixation. This differentiation truly offers the surgeon an excellent and elegant solution to small bone fractures. I genuinely feel it can stand out in what is a crowed space.

Field Orthopaedics CEO, Chris Jefferys, commented: Field Orthopaedics is excited to work within the experienced team at Ortho Consulting Group and expand the Micro Screw range into EMEA. We have the full confidence in OCG‘s ability to capture the market for the Micro Screw and many more to come.”

About Field Orthopaedics

Field Orthopaedics (FO) is an Australian Orthopaedic devices company. FO is a rapidly growing company that focuses on the design and manufacturing of orthopaedic devices to address the shortcomings in the trauma, extremities and biological markets.

Currently, Field Orthopaedics has 12 projects in the entire portfolio, 6 of which are in active development expected to gain regulatory approval within the next 3 years. Field Orthopaedics was formed to bring back innovation to medicine and to realise products that address under-serviced markets and to realise solutions to problems impacting patient care and outcomes. The company was created from within the medical community, when the founders decided to take action and form a significant collaboration with surgeons and physicians asking them what their hurt points were and working alongside them to create answers.

About Ortho Consulting Group

With a network of over 5,000 validated contacts, Ortho Consulting Group (OCG) are a team of industry experts specialising in global strategy and building, strengthening and managing global sales channels, specifically outside of the US.

OCG understand the challenges of growing a global business within Orthopaedics and Spine and offers a holistic consultancy service to advise, support and deliver orthopaedic manufacturers’ expansion strategies.

Made up of two specialist divisions, Orthoconnections and Orthoexecutive, OCG can cover all sales channel expansion solutions, whether that’s growing and onboarding your own senior leadership team or sourcing and managing your distributors.

Media contact:
Tom Edwards, Group Marketing Manager
Ortho Consulting Group

SOURCE Ortho Consulting Group

TDM USA Enters Domestic Extremity Market, Launches Six Product Systems at OTA

TDM USA, based in Salt Lake City, Utah, is pleased to announce its entry into the rapidly expanding US extremity market with the launch of six new product systems at the 2018 Annual Meeting of the Orthopaedic Trauma Association (OTA) in Kissimmee, Florida from October 17-20.

Bringing true value to facilities, surgeons and patients requires going beyond the standard. TDM USA is setting new standards by partnering with medical professionals to define and deliver value-generating solutions for complex healthcare challenges. TDM USA brings a new focus on flexibility to the industry, through its collaborative approach to the unique individual needs of Acute Care Hospitals and Ambulatory Surgery Centers.

The APIS (Advanced Principle Implant System) product group offers surgical solutions for Foot and Ankle, Hand and Wrist, and Shoulder and Elbow. The currently available product offering includes: 2.0mm Locking Plate and Screw System; 2.7mm Locking Plate and Screw System; Proximal Humerus Locking Plate and Screw System; Variable Locking Elbow Plate and Screw System; Variable Locking Foot Plate and Screw System; and Trifix Small Locking Plate and Screw System, a curated product set with a wide variety of plates/screws to address multiple anatomies and procedures in one offering.

“We are excited and humbled by the opportunity to positively impact the US healthcare market by providing high-quality, high-value products for fracture care and extremity reconstruction that have a demonstrated track record around the world,” said Clay Smith, President and General Manager of TDM USA. “In today’s value-driven healthcare environment, our mission is to help achieve clinically equivalent outcomes while reducing costs for providers and patients.”

To learn more about the broad and expanding product portfolio of TDM USA, and its philosophy of value-generating solutions in extremity fixation, please visit and booth 624 during the OTA meeting.


TDM USA has a management team with over 60 years of combined Commercial and Operations experience in the US healthcare sector. TDM USA is a wholly owned subsidiary of TDM Co., Ltd., a global medical device manufacturer headquartered in Gwangju, Korea. TDM Co., Ltd. entered the orthopedic market in 2007 and currently distributes over 40 unique product systems in 15 countries. All available on-market TDM USA products are FDA 510(k) cleared and manufactured to ISO 13485 standards.

3D-Printed Implants Successful in Foot and Ankle Surgery

ROSEMONT, IllinoisOct. 5, 2018 /PRNewswire-HISPANIC PR WIRE/ — According to a new study published in Foot & Ankle International (FAI), advancements in three-dimensional (3D) printing have allowed foot and ankle orthopaedic surgeons to use custom-made implants for difficult foot and ankle cases. The implants offer a new approach to treat complex lower extremity pain and deformities.

Researchers at Duke University Department of Orthopaedic Surgery studied 15 patients who received custom 3D-printed titanium implants between 2014 and 2016 to treat poor bone quality, bone loss, and deformity. In each case, the implants were initially developed by obtaining a computed tomography (CT) scan of the patient and uploading the data to a software program that allowed 3D manipulation of the bones and joints. From there, the senior surgeon and company engineers designed and approved the implant. The benefits of 3D-printed implants include unlimited shapes, increased options in size, and less morbidity or complications.

“This is the first case series looking at the use of 3D-printed implants in foot and ankle surgery,” said Samuel B. Adams, MD, director of foot and ankle research at Duke University Medical Center and senior author of the study. “This short-term study is also the first to demonstrate improvement in patient-reported outcomes with the use of 3D-printed implants. The injuries of many of the patients treated in this study would have required an amputation without this technology.”

CT scans showed that the custom 3D-printed titanium implants were successful in 13 of 15 of the patients who took part in the study. The patients with successful outcomes reported significant improvement in pain and stated they would undergo the same procedure again to save their foot or ankle.

The authors of the study suggest that 3D printing could revolutionize medical care, specifically in modeling for medical education and creating custom artificial body parts. The study notes that longer-term follow-up is needed to understand the longevity and potential complications of these 3D-printed implants.

“The future of 3D printing is very bright. Surgeons who may have been skeptical about using this technology can now use this data to make an informed decision about using it to improve patient care,” said Dr. Adams.

The studyUse of Patient-Specific 3D-Printed Titanium Implants for Complex Foot and Ankle Limb Salvage, Deformity Correction, and Arthrodesis Procedures,” appears in the August 2018 issue of Foot & Ankle International, the official journal of the American Orthopaedic Foot & Ankle Society (AOFAS). FAI is published by SAGE Journals. Author conflicts of interest and funding information are provided within the study.

About Foot and Ankle Orthopaedic Surgeons 
Foot and ankle orthopaedic surgeons are medical doctors (MD and DO) who specialize in the diagnosis and treatment of musculoskeletal disorders and injuries of the foot and ankle. Their education and training consists of four years of medical school, five years of postgraduate residency, and a fellowship year of specialized surgical training. These specialists care for patients of all ages, performing reconstructive surgery for deformities and arthritis, treating sports injuries, and managing foot and ankle trauma.

About the AOFAS 
The American Orthopaedic Foot & Ankle Society (AOFAS) mobilizes our dynamic community of foot and ankle orthopaedic surgeons to improve patient care through education, research, and advocacy. As the premier global organization for foot and ankle care, AOFAS delivers exceptional events and resources for continuous education, funds and promotes innovative research, and broadens patient understanding of foot and ankle conditions and treatments. By emphasizing collaboration and excellence, AOFAS inspires ever-increasing levels of professional performance leading to improved patient outcomes. For more information visit the American Orthopaedic Foot & Ankle Society online at

Logo –

SOURCE American Orthopaedic Foot & Ankle Society

Related Links

Paragon 28® releases another wave of state of the art plating options, adding to the expansive Baby Gorilla® Mini Plating System- launches Medial and Lateral Talar Neck Fracture Plates, Zig Zag Plates, and Zig-Zag Spanning Plates

ENGLEWOOD, Colo.Oct. 3, 2018 /PRNewswire/ — Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

The Baby Gorilla® Medial and Lateral Talar Neck plates are highly contoured in order to fit the unique curvature and anatomy of the talar neck. The plate geometry and screw hole locations are designed in order to provide fixation and stability around commonly observed fracture patterns. Additionally, the medial talar neck plate contains extended bridge lengths to accommodate ancillary fixation should cross screw fixation be appropriate.

The Lateral Talar Neck Plates come in two sizes, both small and medium for left and right feet while the medial talar neck plate is offered in a left and right option.

The Zig Zag and Zig Zag Spanning plates can be used universally in application but excel when addressing highly comminuted areas, revisions, hardware removal and metatarsal fractures. The Zig Zag plates come in multiple lengths and screw hole options, from a 5-hole plate up to as large as a 19-hole option. Additionally, the Zig Zag Spanning plate comes in three length options to address the needs of each patient.

The modularity of the Baby Gorilla® Mini Plating system allows both small plate caddies to utilize the same screws and instrumentation used by all other 80+ Baby Gorilla® plating options, all in a single set. All plates are designed to accept both 2.0mm and 2.5mm locking and non-locking plate screws. Additionally, the Baby Gorilla® system includes state of the art foot and ankle specific instrumentation including curettes, reduction clamps, osteotomes, as well as small pin compression and distraction devices.

For more information, contact: Jim Edson, VP of Product Marketing and Management,

SOURCE Paragon 28, Inc.

Trice Medical Launches the World’s First Dynamic Imaging Platform, Adding Ultrasound Capability to the mi-eye®

MALVERN, Pa.Oct. 2, 2018 /PRNewswire/ — U.S. based Trice Medical, Inc. announced today the launch of its latest product, mi-ultra™, a high powered 15mHz handheld ultrasound transducer. The mi-ultra™ is enabled by the same platform technology that Trice’s flagship product, mi-eye 2®, operates on, the mi-tablet.

The mi-ultra™, which comes in both convex and linear offerings, has been optimized for Muscular Skeletal (MSK) applications. The addition of this technology to Trice’s Dynamic Imaging Platform will enable orthopedic practices to provide a full suite of MSK imaging at the first point of care. The ability to provide a dynamic evaluation for patients, as opposed to static systems like MRI and X-Ray, has never been easier for orthopedic offices with this all-in-one portable system.

Dr. Don Buford, orthopedic surgeon and founder of the Dallas PRP and Stem Cell Institute, said, “The mi-ultra™ is a combination of the first MSK ultrasound system with sufficient image quality and reliability for all diagnostic and procedure indications with the first tablet based disposable office needle arthroscopy platform. Now, every orthopedic clinician can have a single portable tablet for imaging intra-articular and extra-articular anatomy for diagnosis and procedures. This is a truly revolutionary point of care imaging system and the only such platform available!”

The early success of Trice Medical’s mi-eye 2®, which was launched in the U.S. in 2017, has captured the attention of medical professionals who are embracing the technology as a new diagnostic modality. After the first year of commercial launch, the mi-eye® is currently being used by over 300 institutions across the U.S. The disposable needle embedded with a wide-angle camera lens enables physicians to diagnose joint injuries right in their clinic; deliver biological under direct visualization; and provide their patients with immediate answers to the cause of their pain.

“This is a truly disruptive technology for the orthopedic industry,” said Mark Foster, President and CCO of Trice Medical. “Today’s healthcare environment is asking for innovation in a cost-effective manner. Trice is proud to have combined an arthroscopy tower and a high-powered ultrasound system into one simple, portable tablet. The disposable mi-eye 2®camera is great to identify pathology within the joint and the mi-ultra is a perfect complement for guided injections or assessing soft tissue damage outside of the joint. We believe the system is a “must have” for every orthopedic practice.”

About the mi-eye 2®:

Trice Medical’s mi-eye 2® is a handheld, single-use, and disposable direct visualization tool. The mi-eye 2® was specifically designed for use in the clinic setting, consisting of a single stick percutaneous, and self-blunting design which deploys an integrated camera and a light source. The procedure is performed with local anesthetic and provides patients with an alternative to traditional diagnostic modalities, such as time-consuming and often inaccurate MRIs. The mi-eye® is indicated for use in diagnostic and operative arthroscopic and endoscopic procedures to provide illumination and visualization of an interior cavity of the body through either a natural or surgical opening. The mi-eye 2® is available for prescription use only.

About Trice Medical:

Trice Medical was founded to fundamentally improve orthopedic diagnostics for the patient, and the physician providing instant answers. Trice Medical has pioneered fully integrated camera-enabled technology, the mi-eye 2®, that provides a clinical solution optimized for the physician’s office. Trice Medical’s mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.

Contact Trice Medical:

+1 (610) 989-8080

Trice Medical’s mi-eye 2

Related Links

Trice Medical

SOURCE Trice Medical

Related Links

Prominent Hand Surgeon Joins NYU Langone Health To Spearhead Orthopedic Innovation

NEW YORK Oct. 2, 2018 /PRNewswire/ — Thomas J. Graham, MD, one of the nation’s most respected hand surgeons and health care innovators, recently joined the Department of Orthopedic Surgery at NYU Langone Health as Director of Strategy and Innovation. Dr. Graham is also serving as Associate Chief of the Division of Hand Surgery.

Dr. Graham will see patients at NYU Langone’s Hand Center, where he is moving his clinical practice — which has treated thousands of professional athletes and performed hand and elbow surgeries of all complexities. Dr. Graham, who joined NYU Langone on September 1, has a national and international reputation as a hand and upper extremity surgeon, and a pioneer in orthopedic innovation.

“We are incredibly fortunate to recruit Dr. Graham to NYU Langone, and to bring his renowned skills as a hand surgeon, innovator and physician leader to our department,” says Joseph D. Zuckerman, MD, the Walter A. L. Thompson Professor of Orthopedic Surgery and chair of the Department of Orthopedic Surgery. “Having a surgeon and visionary like Dr. Graham join our already outstanding hand surgery faculty further catapults our top-ranked program to an even higher level of excellence.”

Sought-After Hand Surgeon to Athletes

Dr. Graham has extensive clinical expertise in surgery of the hand, wrist and elbow, with particular expertise in complicated reconstruction after trauma, complex elbow disorders, and congenital hand ailments. His practice also enjoys worldwide recognition for care of the hand and wrist of professional athletes. Notably, he has served as the hand surgery consultant, team physician or medical director for numerous professional sports teams in the NFL, MLB, NBA, NHL, and the PGA and LPGA Tours, and has personally cared for thousands of elite athletes.

An alumnus of Williams College, Dr. Graham received his medical degree at the University of Cincinnati College of Medicine. He completed his orthopedic surgery residency at the University of Michigan, followed by a fellowship in hand and upper extremity surgery at the Indiana Hand Center, and extended training in surgery of the elbow at the Mayo Clinic.

In addition, he completed a two-year executive management and healthcare administration program sponsored by Cleveland Clinic and Weatherhead School of Management at Case Western Reserve University.

Following his initial faculty appointment at Cleveland Clinic where he was director of the Hand and Upper Extremity Center, Dr. Graham relocated to Baltimore to serve as chief of the congressionally designated Curtis National Hand Center, the largest specialty practice in its field globally, and Vice- Chairman of Orthopedic Surgery at MedStar Union Memorial Hospital. Dr. Graham also was an Associate Professor of both orthopedic and plastic surgery at Johns Hopkins Medicine. While in Baltimore, he also established MedStar SportsHealth and was the founder and Surgeon-in-Chief of the Arnold Palmer Sports Health Center.

After his considerable contributions in Baltimore, Dr. Graham returned to Cleveland Clinic, where he served as its inaugural Chief Innovation Officer and Vice Chairman of Orthopedic Surgery.

An accomplished academician, Dr. Graham has lectured around the world and advanced his specialty by authoring more than 100 publications, numerous books and book chapters, including the best-seller, “Innovation the Cleveland Clinic Way.

Enhancing Orthopedic Innovation

Dr. Graham’s history as a prolific innovator and inventor includes holding more than 50 patents for medical devices, primarily implants to treat fractures or replace joints of the upper extremity. He also is an entrepreneur in his own right, and has started several public and private medical device and artificial intelligence companies.

In his new role at NYU Langone, Dr. Graham will take his vast experience translating strategy and innovation into tangible advancements in techniques, technologies and the delivery of orthopedic care.

“NYU Langone has impressed me with its commitment to innovation and collaboration, where colleagues embrace the responsibilities and opportunities that come with clinical and academic leadership,” Dr. Graham says. “I recognize championship organizations, and I’m honored to join yet another. NYU Langone’s Department of Orthopedic Surgery remains at the vanguard of our specialty by optimizing outcomes and the patient experience.”

Media Contact:
Ryan Jaslow

SOURCE NYU Langone Health